z-logo
open-access-imgOpen Access
Biosynthesis, characterisation and antimicrobial activity of zinc oxide and nickel doped zinc oxide nanoparticles using Euphorbia abyssinica bark extract
Author(s) -
Faye Gezahegn,
Jebessa Tola,
Wubalem Tilahun
Publication year - 2022
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.366
H-Index - 38
eISSN - 1751-875X
pISSN - 1751-8741
DOI - 10.1049/nbt2.12072
Subject(s) - zinc , nanoparticle , materials science , wurtzite crystal structure , nuclear chemistry , nickel oxide , aspergillus niger , fourier transform infrared spectroscopy , euphorbia , antimicrobial , nickel , chemistry , nanotechnology , organic chemistry , chemical engineering , botany , biochemistry , metallurgy , biology , engineering
Abstract Biosynthesis of metallic oxide nanoparticles is being used and preferred over physical and chemical methods of synthesis since it is simple, inexpensive, environmentally friendly, and green. The aim of this study was to synthesise ZnO and nickel doped ZnO nanoparticles using Euphorbia abyssinica bark extract for antimicrobial activity studies via agar disk diffusion method against some selected microbes. The synthesised nanoparticles were characterised using X‐ray diffraction (XRD), ultraviolet–visible spectroscopy, and Fourier transform infrared spectroscopy. The study results revealed that the biosynthesised nanoparticles had good crystalline nature, with crystal sizes in the range of nanoparticles and structures of hexagonal wurtzite. Both undoped ZnO and nickel doped ZnO nanoparticles demonstrated antibacterial and antifungal activity against four bacterial strains and two fungal genus. Generally, nickel doped ZnO NPs were found to possess more antimicrobial activities than undoped ZnO NPs. Specially, 4% and 5% nickel doped ZnO NPs showed significantly enhanced activity against Enterococcus faecalis, Staphylococcus aureus, Aspergillus and Fusarium .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here